Plus decriminalization in a Washington town and a new paper on models of consciousness and the psychedelic experience.
This Week In Psychedelics: The science behind FTO’s Compass patent challenges, living with HPPD, big pharma invests in psychedelics, and more
This Week In Psychedelics: The science behind…
This Week In Psychedelics: The science behind FTO’s Compass patent challenges, living with HPPD, big pharma invests in psychedelics, and more
Plus decriminalization in a Washington town and a new paper on models of consciousness and the psychedelic experience.